» Authors » Sylvie Rebuffat

Sylvie Rebuffat

Explore the profile of Sylvie Rebuffat including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 77
Citations 3173
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Telhig S, Pham N, Ben Said L, Rebuffat S, Ouellette M, Zirah S, et al.
Microb Genom . 2024 Feb; 10(2). PMID: 38407259
produce an arsenal of antimicrobial compounds including microcins, ribosomally produced antimicrobial peptides showing diverse structures and mechanisms of action. Microcins target close relatives of the producing strain to promote its...
2.
Baquero F, Beis K, Craik D, Li Y, Link A, Rebuffat S, et al.
Nat Prod Rep . 2024 Jan; 41(3):469-511. PMID: 38164764
Covering: 1992 up to 2023Since their discovery, lasso peptides went from peculiarities to be recognized as a major family of ribosomally synthesized and post-translationally modified peptide (RiPP) natural products that...
3.
Leroy C, Spelier S, Essonghe N, Poix V, Kong R, Gizzi P, et al.
Mol Ther . 2023 Jan; 31(4):970-985. PMID: 36641622
Nonsense mutations are responsible for around 10% of cases of genetic diseases, including cystic fibrosis. 2,6-diaminopurine (DAP) has recently been shown to promote efficient readthrough of UGA premature stop codons....
4.
Madi-Moussa D, Deracinois B, Teiar R, Li Y, Mihasan M, Flahaut C, et al.
Pharmaceutics . 2022 Sep; 14(9). PMID: 36145669
Lacticaseicin 30 is one of the five bacteriocins produced by the Gram-positive CNCM I-5369. This 111 amino acid bacteriocin is noteworthy for being active against Gram-negative bacilli including strains resistant...
5.
Naimi S, Zirah S, Greppi A, Lacroix C, Rebuffat S, Fliss I
Front Microbiol . 2022 Aug; 13:930392. PMID: 35992668
The increased prevalence of spp. resistance in swine spurs the search for alternatives to antibiotics. Microcin J25 (MccJ25), a bacteriocin produced by , is a potent inhibitor of several pathogenic...
6.
Telhig S, Ben Said L, Torres C, Rebuffat S, Zirah S, Fliss I
Microbiol Spectr . 2022 May; 10(3):e0275221. PMID: 35543514
The advent of multidrug-resistant bacteria has hampered the development of new antibiotics, exacerbating their morbidity and mortality. In this context, the gastrointestinal tract reveals a valuable source of novel antimicrobials....
7.
Soltani S, Zirah S, Rebuffat S, Couture F, Boutin Y, Biron E, et al.
Front Microbiol . 2022 Feb; 12:780355. PMID: 35145490
Bacteriocins are receiving increased attention as potent candidates in food preservation and medicine. Although the inhibitory activity of bacteriocins has been studied widely, little is known about their gastrointestinal stability...
8.
Rebuffat S
Nat Prod Rep . 2021 Nov; 39(2):273-310. PMID: 34755755
It is currently well established that multicellular organisms live in tight association with complex communities of microorganisms including a large number of bacteria. These are immersed in complex interaction networks...
9.
Ghilarov D, Inaba-Inoue S, Stepien P, Qu F, Michalczyk E, Pakosz Z, et al.
Sci Adv . 2021 Sep; 7(37):eabj5363. PMID: 34516884
Antibiotic metabolites and antimicrobial peptides mediate competition between bacterial species. Many of them hijack inner and outer membrane proteins to enter cells. Sensitivity of enteric bacteria to multiple peptide antibiotics...
10.
Jeanne Dit Fouque K, Scutelnic V, Hegemann J, Rebuffat S, Maitre P, Rizzo T, et al.
J Am Soc Mass Spectrom . 2021 Mar; 32(4):1096-1104. PMID: 33765377
Lasso peptides form a class of ribosomally synthesized and post-translationally modified peptides (RiPPs) characterized by a mechanically interlocked topology, where the C-terminal tail of the peptide is threaded and trapped...